Genetically predicted plasma levels of amino acids and metabolic dysfunction-associated fatty liver disease risk: a Mendelian randomization study.
Jian ZhaoJing ZengCairong ZhuXuechao LiDong LiuJun ZhangFei LiGiovanni TargherJian-Gao FanPublished in: BMC medicine (2023)
Novel causal metabolites related to MAFLD development were uncovered through MR analysis, suggesting future potential for evaluating these metabolites as targets for MAFLD prevention or treatment.